
Kauser M. Akhoon
Examiner (ID: 9527, Phone: (571)270-1026 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642, 1613 |
| Total Applications | 267 |
| Issued Applications | 151 |
| Pending Applications | 2 |
| Abandoned Applications | 116 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9338869
[patent_doc_number] => 20140065651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'DESTRUCTIBLE SURFACTANTS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/075637
[patent_app_country] => US
[patent_app_date] => 2013-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9943
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14075637
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/075637 | Destructible surfactants and uses thereof | Nov 7, 2013 | Issued |
Array
(
[id] => 10373204
[patent_doc_number] => 20150258210
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-09-17
[patent_title] => 'MODIFIED ANTIBODY, ANTIBODY-CONJUGATE AND PROCESS FOR THE PREPARATION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/437808
[patent_app_country] => US
[patent_app_date] => 2013-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 35639
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 38
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437808
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437808 | Modified antibody, antibody-conjugate and process for the preparation thereof | Oct 22, 2013 | Issued |
Array
(
[id] => 12960364
[patent_doc_number] => 09872924
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-01-23
[patent_title] => Antibody-drug conjugate produced by binding through linker having hydrophilic structure
[patent_app_type] => utility
[patent_app_number] => 14/436458
[patent_app_country] => US
[patent_app_date] => 2013-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 68073
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 422
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14436458
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/436458 | Antibody-drug conjugate produced by binding through linker having hydrophilic structure | Oct 16, 2013 | Issued |
Array
(
[id] => 10398251
[patent_doc_number] => 20150283259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-08
[patent_title] => 'DRUG-PROTEIN CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 14/437571
[patent_app_country] => US
[patent_app_date] => 2013-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9105
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14437571
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/437571 | DRUG-PROTEIN CONJUGATES | Oct 10, 2013 | Abandoned |
Array
(
[id] => 13207203
[patent_doc_number] => 10117952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Antibody-drug conjugate
[patent_app_type] => utility
[patent_app_number] => 14/435114
[patent_app_country] => US
[patent_app_date] => 2013-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 64369
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435114 | Antibody-drug conjugate | Oct 9, 2013 | Issued |
Array
(
[id] => 13207203
[patent_doc_number] => 10117952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Antibody-drug conjugate
[patent_app_type] => utility
[patent_app_number] => 14/435114
[patent_app_country] => US
[patent_app_date] => 2013-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 64369
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435114 | Antibody-drug conjugate | Oct 9, 2013 | Issued |
Array
(
[id] => 13207203
[patent_doc_number] => 10117952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Antibody-drug conjugate
[patent_app_type] => utility
[patent_app_number] => 14/435114
[patent_app_country] => US
[patent_app_date] => 2013-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 64369
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435114 | Antibody-drug conjugate | Oct 9, 2013 | Issued |
Array
(
[id] => 13207203
[patent_doc_number] => 10117952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-06
[patent_title] => Antibody-drug conjugate
[patent_app_type] => utility
[patent_app_number] => 14/435114
[patent_app_country] => US
[patent_app_date] => 2013-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 64369
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14435114
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/435114 | Antibody-drug conjugate | Oct 9, 2013 | Issued |
Array
(
[id] => 11814952
[patent_doc_number] => 09718894
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-08-01
[patent_title] => 'Bioprocessing device'
[patent_app_type] => utility
[patent_app_number] => 14/046154
[patent_app_country] => US
[patent_app_date] => 2013-10-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 28
[patent_no_of_words] => 12482
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14046154
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/046154 | Bioprocessing device | Oct 3, 2013 | Issued |
Array
(
[id] => 9661771
[patent_doc_number] => 08808741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-08-19
[patent_title] => 'Tamper resistant dosage forms'
[patent_app_type] => utility
[patent_app_number] => 14/040535
[patent_app_country] => US
[patent_app_date] => 2013-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 43
[patent_no_of_words] => 66028
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14040535
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/040535 | Tamper resistant dosage forms | Sep 26, 2013 | Issued |
Array
(
[id] => 9269752
[patent_doc_number] => 20140024669
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'TAMPER RESISTANT DOSAGE FORMS'
[patent_app_type] => utility
[patent_app_number] => 14/038209
[patent_app_country] => US
[patent_app_date] => 2013-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 29
[patent_figures_cnt] => 29
[patent_no_of_words] => 66006
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14038209
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/038209 | TAMPER RESISTANT DOSAGE FORMS | Sep 25, 2013 | Abandoned |
Array
(
[id] => 9269773
[patent_doc_number] => 20140024691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-23
[patent_title] => 'FORMULATIONS OF BENDAMUSTINE'
[patent_app_type] => utility
[patent_app_number] => 14/031879
[patent_app_country] => US
[patent_app_date] => 2013-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5785
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14031879
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/031879 | Formulations of bendamustine | Sep 18, 2013 | Issued |
Array
(
[id] => 10331974
[patent_doc_number] => 20150216977
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-08-06
[patent_title] => 'STABLE PHARMACEUTICAL COMPOSITION, COMPRISING AN AQUEOUS SOLUTION OF AN ANTIBODY-DERIVED THERAPEUTICALLY ACTIVE PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 14/428860
[patent_app_country] => US
[patent_app_date] => 2013-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8055
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14428860
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/428860 | STABLE PHARMACEUTICAL COMPOSITION, COMPRISING AN AQUEOUS SOLUTION OF AN ANTIBODY-DERIVED THERAPEUTICALLY ACTIVE PROTEIN | Sep 17, 2013 | Abandoned |
Array
(
[id] => 9250163
[patent_doc_number] => 08613941
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2013-12-24
[patent_title] => 'Synergistic antimicrobial composition'
[patent_app_type] => utility
[patent_app_number] => 14/025862
[patent_app_country] => US
[patent_app_date] => 2013-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1948
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14025862
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/025862 | Synergistic antimicrobial composition | Sep 12, 2013 | Issued |
Array
(
[id] => 13156233
[patent_doc_number] => 10094834
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Method of selecting individualized brain cancer therapy
[patent_app_type] => utility
[patent_app_number] => 14/424400
[patent_app_country] => US
[patent_app_date] => 2013-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 5063
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14424400
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/424400 | Method of selecting individualized brain cancer therapy | Aug 28, 2013 | Issued |
Array
(
[id] => 9198851
[patent_doc_number] => 20130338166
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'REDUCING SIDE EFFECTS OF TRAMADOL'
[patent_app_type] => utility
[patent_app_number] => 13/970198
[patent_app_country] => US
[patent_app_date] => 2013-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 9956
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13970198
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/970198 | REDUCING SIDE EFFECTS OF TRAMADOL | Aug 18, 2013 | Abandoned |
Array
(
[id] => 9223559
[patent_doc_number] => 20140018334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-16
[patent_title] => 'Oral Dosage Forms of Bendamustine'
[patent_app_type] => utility
[patent_app_number] => 13/932785
[patent_app_country] => US
[patent_app_date] => 2013-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10239
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13932785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/932785 | Oral Dosage Forms of Bendamustine | Jun 30, 2013 | Abandoned |
Array
(
[id] => 9206084
[patent_doc_number] => 20140005261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'RACECADOTRIL LIQUID COMPOSITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/929975
[patent_app_country] => US
[patent_app_date] => 2013-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3716
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13929975
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/929975 | Racecadotril liquid compositions | Jun 27, 2013 | Issued |
Array
(
[id] => 13013917
[patent_doc_number] => 10030066
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-24
[patent_title] => Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor
[patent_app_type] => utility
[patent_app_number] => 14/434743
[patent_app_country] => US
[patent_app_date] => 2013-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 5474
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14434743
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/434743 | Immune receptor modifier conjugate and preparation method and use thereof, coupling precursor for preparing same, and compound for synthesizing coupling precursor | Jun 25, 2013 | Issued |
Array
(
[id] => 9205014
[patent_doc_number] => 20140004190
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'Solid Dosage Forms of Bendamustine'
[patent_app_type] => utility
[patent_app_number] => 13/917144
[patent_app_country] => US
[patent_app_date] => 2013-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20822
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917144
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/917144 | Solid Dosage Forms of Bendamustine | Jun 12, 2013 | Abandoned |